Financials

News Discussions Technicals Forecast Seasonals

CINPHA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Cinclus Pharma Holding AB is a Swedish clinical-stage pharma company and it operates as a holding company through its subsidiaries. It develops small molecules for treatment of stomach acid related diseases with a focus on the diseases GastroEsophageal Reflux Disease (GERD) and Helicobacter Pylori Infection. The company was founded by Hansson Stig Lennart, Unge Peter, Kjell Andersson and Paulsson Urban in 2014 and is headquartered in Stockholm, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

CINPHA does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company